| Literature DB >> 16176982 |
Takahiro Nobukuni1, Manel Joaquin, Marta Roccio, Stephen G Dann, So Young Kim, Pawan Gulati, Maya P Byfield, Jonathan M Backer, Francois Natt, Johannes L Bos, Fried J T Zwartkruis, George Thomas.
Abstract
During the evolution of metazoans and the rise of systemic hormonal regulation, the insulin-controlled class 1 phosphatidylinositol 3OH-kinase (PI3K) pathway was merged with the primordial amino acid-driven mammalian target of rapamycin (mTOR) pathway to control the growth and development of the organism. Insulin regulates mTOR function through a recently described canonical signaling pathway, which is initiated by the activation of class 1 PI3K. However, how the amino acid input is integrated with that of the insulin signaling pathway is unclear. Here we used a number of molecular, biochemical, and pharmacological approaches to address this issue. Unexpectedly, we found that a major pathway by which amino acids control mTOR signaling is distinct from that of insulin and that, instead of signaling through components of the insulin/class 1 PI3K pathway, amino acids mediate mTOR activation by signaling through class 3 PI3K, hVps34.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16176982 PMCID: PMC1242323 DOI: 10.1073/pnas.0506925102
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205